Correction to: An evaluation of the response to neoadjuvant chemotherapy for osteosarcoma of extremities: PERCIST versus RECIST 1.1 criteria after long-term follow-up.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Ann Nucl Med

Title: Annals of nuclear medicine

Publisher: Springer Science and Business Media LLC

ISSN (Electronic): 1864-6433

ISSN (Print): 0914-7187

Publication date (Electronic): Aug 2022

Volume: 36

Issue: 8

Affiliations

[1 ] Musculoskeletal Tumor Center, Peking University People's Hospital, 11 Xizhimen South Street, Beijing, China.

[2 ] Department of Nuclear Medicine, Peking University People's Hospital, 11 Xizhimen South Street, Beijing, China.

[3 ] Department of Pathology, Peking University People's Hospital, 11 Xizhimen South Street, Beijing, China.

[4 ] Musculoskeletal Tumor Center, Peking University People's Hospital, 11 Xizhimen South Street, Beijing, China. bonetumor@163.com.

Article

Publisher Item ID: 10.1007/s12149-022-01768-y

DOI: 10.1007/s12149-022-01768-y

PubMed ID: 35751837

SO-VID: 924ec15d-1e3a-40ed-bb22-a2c427c7841d

History

Data availability:

Correction to: An evaluation of the response to neoadjuvant chemotherapy for osteosarcoma of extremities: PERCIST versus RECIST 1.1 criteria after long-term follow-up.

Read this article at

Related collections

Procedural speed in criminal law

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 1,803

Cited by 1